Long-term Impact of Bariatric Surgery in Diabetic Nephropathy
Overview
General Surgery
Radiology
Affiliations
Background: Bariatric surgery has been shown to improve and resolve diabetes. However, limited literature about its impact on end-organ complications of diabetes is available. The aim of this study was to examine the long-term effect of bariatric surgery on albuminuria.
Methods: We studied 101 patients with pre-operative diabetes and albuminuria [defined as urine albumin:creatinine ratio (uACR) > 30 mg/g] who underwent bariatric surgery at an academic center from 2005 to 2014.
Results: Fifty-seven patients (56%) were female with a mean age of 53 (± 11) years. The mean pre-operative BMI and glycated hemoglobin (HbA1c) were 43.1 (± 7.6) kg/m and 8.4 (± 1.8)%, respectively. The median pre-operative uACR was 80.0 (45.0-231.0) mg/g. Bariatric procedures included Roux-en-Y gastric bypass (n = 75, 74%) and sleeve gastrectomy (n = 26, 26%). The mean follow-up period was 61 (± 29) months. At last follow-up, the mean BMI was 33.8 (± 8.3) kg/m. The overall glycemic control improved after bariatric surgery. At last follow-up, 73% had good glycemic control (HbA1c < 7%) and 27% met diabetes remission criteria. The mean HbA1c at last follow-up was 6.7 (± 1.0)% and the median uACR was 30 (IQR 7-94) mg/g. Albuminuria improved in 77% and resolved in 51% of patients at long-term.
Conclusions: Bariatric surgery has a significantly positive impact on albuminuria in patients with obesity and type 2 diabetes. Our data showed almost an 80% improvement in albuminuria at the short- and long-term period after bariatric surgery.
Juca R, Bregion P, de Oliveira-Filho J, da Rocha Soares G, Juca S, Ivano V Obes Surg. 2025; 35(2):587-601.
PMID: 39775393 DOI: 10.1007/s11695-025-07669-z.
Liu C, Zhong M, Jin X, Zhu J, Cheng Y, Li L J Endocrinol Invest. 2024; 47(7):1763-1776.
PMID: 38512446 PMC: 11196306. DOI: 10.1007/s40618-023-02267-1.
Abdel-Rahman I, Alharbi A, Alsaedi M, Alharbi N, Al-Mughassil S, Al-Bahar Z Cureus. 2024; 16(1):e53295.
PMID: 38435872 PMC: 10905210. DOI: 10.7759/cureus.53295.
Vasdeki D, Koufakis T, Tsamos G, Busetto L, Zebekakis P, Kotsa K Nutrients. 2022; 14(22).
PMID: 36432488 PMC: 9695991. DOI: 10.3390/nu14224801.
Bariatric surgery for diabetic comorbidities: A focus on hepatic, cardiac and renal fibrosis.
Ding H, Zhang Y, Ma X, Zhang Z, Xu Q, Liu C Front Pharmacol. 2022; 13:1016635.
PMID: 36339532 PMC: 9634081. DOI: 10.3389/fphar.2022.1016635.